139 related articles for article (PubMed ID: 19716430)
1. Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases.
Pillarisetti S; Alexander CW; Khanna I
Drug Discov Today; 2009 Dec; 14(23-24):1098-111. PubMed ID: 19716430
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
Fezza F; De Simone C; Amadio D; Maccarrone M
Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
Gertsch J
Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid amide hydrolase: from characterization to therapeutics.
Labar G; Michaux C
Chem Biodivers; 2007 Aug; 4(8):1882-902. PubMed ID: 17712824
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function.
Schmid HH; Berdyshev EV
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):363-76. PubMed ID: 12052050
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
Saario SM; Laitinen JT
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):287-93. PubMed ID: 17910610
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system: current pharmacological research and therapeutic possibilities.
Jonsson KO; Holt S; Fowler CJ
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):124-34. PubMed ID: 16445584
[TBL] [Abstract][Full Text] [Related]
9. Functional disassociation of the central and peripheral fatty acid amide signaling systems.
Cravatt BF; Saghatelian A; Hawkins EG; Clement AB; Bracey MH; Lichtman AH
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10821-6. PubMed ID: 15247426
[TBL] [Abstract][Full Text] [Related]
10. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
[TBL] [Abstract][Full Text] [Related]
11. Targeting the cannabinoid system to produce analgesia.
Sagar DR; Jhaveri M; Chapman V
Curr Top Behav Neurosci; 2009; 1():275-87. PubMed ID: 21104388
[TBL] [Abstract][Full Text] [Related]
12. Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo V
Nat Rev Drug Discov; 2008 May; 7(5):438-55. PubMed ID: 18446159
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).
Lodola A; Castelli R; Mor M; Rivara S
Expert Opin Ther Pat; 2015; 25(11):1247-66. PubMed ID: 26413912
[TBL] [Abstract][Full Text] [Related]
14. Targeted lipidomics: fatty acid amides and pain modulation.
Walker JM; Krey JF; Chen JS; Vefring E; Jahnsen JA; Bradshaw H; Huang SM
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):35-45. PubMed ID: 16099389
[TBL] [Abstract][Full Text] [Related]
15. The enzymatic inactivation of the fatty acid amide class of signaling lipids.
Cravatt BF; Lichtman AH
Chem Phys Lipids; 2002 Dec; 121(1-2):135-48. PubMed ID: 12505696
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract.
Sałaga M; Sobczak M; Fichna J
Eur J Pharm Sci; 2014 Feb; 52():173-9. PubMed ID: 24275607
[TBL] [Abstract][Full Text] [Related]
17. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of cannabinoid receptors and their ligands: an overview.
Pertwee RG
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid amide hydrolase controls mouse intestinal motility in vivo.
Capasso R; Matias I; Lutz B; Borrelli F; Capasso F; Marsicano G; Mascolo N; Petrosino S; Monory K; Valenti M; Di Marzo V; Izzo AA
Gastroenterology; 2005 Sep; 129(3):941-51. PubMed ID: 16143133
[TBL] [Abstract][Full Text] [Related]
20. A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase.
Kage KL; Richardson PL; Traphagen L; Severin J; Pereda-Lopez A; Lubben T; Davis-Taber R; Vos MH; Bartley D; Walter K; Harlan J; Solomon L; Warrior U; Holzman TF; Faltynek C; Surowy CS; Scott VE
J Neurosci Methods; 2007 Mar; 161(1):47-54. PubMed ID: 17083980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
